HSV therapy and HIV-1 reduction.
Eisenhut
Michael
M
D000212:Acyclovir / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D015658:HIV Infections / Q000150:complications*; D015497:HIV-1 / Q000187:drug effects* / Q000502:physiology; D006561:Herpes Simplex / Q000188:drug therapy*; D006801:Humans; D012367:RNA, Viral / Q000032:analysis; D000077483:Valacyclovir; D014633:Valine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D019562:Viral Load; D014779:Virus Replication
D000998:Antiviral Agents; D012367:RNA, Viral; D014633:Valine; D000077483:Valacyclovir; D000212:Acyclovir